Authors:
Schick, BP
Gradowski, JF
San Antonio, JD
Martinez, J
Citation: Bp. Schick et al., Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans, THROMB HAEM, 85(3), 2001, pp. 482-487
Citation: Ke. Forsten et al., Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment, J CELL PHYS, 189(3), 2001, pp. 356-365
Citation: Bp. Schick et al., Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells, BLOOD, 97(2), 2001, pp. 449-458
Authors:
Shi, Y
Niculescu, R
Wang, D
Ormont, M
Magno, M
San Antonio, JD
Williams, KJ
Zalewski, A
Citation: Y. Shi et al., Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair, J VASC RES, 37(5), 2000, pp. 399-407
Authors:
Keene, DR
San Antonio, JD
Mayne, R
McQuillan, DJ
Sarris, G
Santoro, S
Iozzo, RV
Citation: Dr. Keene et al., Acceleracted publication - Decorin binds near the C terminus of type I collagen, J BIOL CHEM, 275(29), 2000, pp. 21801-21804
Authors:
Shirk, RA
Parthasarathy, N
San Antonio, JD
Church, FC
Wagner, WD
Citation: Ra. Shirk et al., Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque, J BIOL CHEM, 275(24), 2000, pp. 18085-18092
Authors:
Verrecchio, A
Germann, MW
Schick, BP
Kung, B
Twardowski, T
San Antonio, JD
Citation: A. Verrecchio et al., Design of peptides with high affinities for heparin and endothelial cell proteoglycans, J BIOL CHEM, 275(11), 2000, pp. 7701-7707